Publication:
Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.

Simple item page
dc.contributor.authorBoran, T
dc.contributor.authorAkyildiz, AYŞENUR
dc.contributor.authorJannuzzi, AT
dc.contributor.authorAlpertunga, B
dc.contributor.institutionauthorGÜNAYDIN AKYILDIZ, AYŞENUR
dc.date.accessioned2020-11-21T11:02:39Z
dc.date.available2020-11-21T11:02:39Z
dc.date.issued2020-11-06T00:00:00Z
dc.description.sponsorshipİstanbul Üniversitesi
dc.description.sponsorshipİstanbul Üniversitesi
dc.identifier.citationBoran T., Akyildiz A., Jannuzzi A., Alpertunga B., -Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.-, Toxicology letters, 2020
dc.identifier.doi10.1016/j.toxlet.2020.11.003
dc.identifier.pubmed33166663
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27394
dc.titleExtended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id4c28c9f8-e41d-47b9-ba4a-9f78bb1a98d1
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication98a70592-2158-4e37-b8d7-80d3bd64c98c
relation.isAuthorOfPublication.latestForDiscovery98a70592-2158-4e37-b8d7-80d3bd64c98c
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Yayınlar - Eserler